Disposition of flavonoids via recycling: Comparison of intestinal versus hepatic disposition

被引:74
作者
Chen, J [1 ]
Wang, S [1 ]
Jia, XB [1 ]
Bajimaya, S [1 ]
Lin, HM [1 ]
Tam, VH [1 ]
Hu, M [1 ]
机构
[1] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA
关键词
D O I
10.1124/dmd.105.003673
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The purpose of this study was to compare intestinal versus hepatic disposition of six flavonoids to fully characterize their first-pass metabolism. The perfused rat intestinal model and microsomes prepared from rat liver, duodenum, jejunum, ileum, and colon were used. The results indicated that isoflavone (12.5 mu M) glucuronidation was highly variable among different microsomes prepared from liver or intestine. Comparing to liver metabolism, the intestinal metabolism had higher K-m values (> 2-fold). Likewise, the hepatic intrinsic clearance (IC, or a ratio of V-max/K-m) values of isoflavones were generally higher than their intestinal IC values (200-2000% higher), except for prunetin, for which the jejunal IC value was 50% higher than its hepatic IC. When comparing intestinal metabolism, the results showed that intestinal metabolism rates and V-max values of isoflavones were less when an additional A-ring electron-donating group was absent (i.e., daidzein and formononetin). In the rat perfusion model using the whole small intestine, genistein (10 mu M) was well absorbed (77% or 352 nmol/120 min). The first-pass metabolism of genistein was extensive, with 40% of absorbed genistein excreted as conjugated metabolites into the intestinal lumen. In contrast, the bile excretion of genistein conjugates was much less (6.4% of absorbed genistein). In conclusion, intestinal glucuronidation is slower in isoflavones without an additional A-ring substitution. Perfusion studies suggest that intestine is the main organ for genistein glucuronide formation and excretion in rats and may serve as its main first-pass metabolism organ.
引用
收藏
页码:1777 / 1784
页数:8
相关论文
共 24 条
[1]
ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[2]
Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[3]
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men [J].
Busby, MG ;
Jeffcoat, AR ;
Bloedon, LT ;
Koch, MA ;
Black, T ;
Dix, KJ ;
Heizer, WD ;
Thomas, BF ;
Hill, JM ;
Crowell, JA ;
Zeisel, SH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (01) :126-136
[4]
Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model [J].
Chen, J ;
Lin, HM ;
Hu, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (02) :159-169
[5]
Metabolism of flavonoids via enteric recycling: Role of intestinal disposition [J].
Chen, J ;
Lin, HM ;
Hu, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03) :1228-1235
[6]
D'Argenio DZ, 1997, ADAPT 2 USERS GUIDE
[7]
Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract [J].
Grams, B ;
Harms, A ;
Braun, S ;
Strassburg, CP ;
Manns, MP ;
Obermayer-Straub, P .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 377 (02) :255-265
[8]
Houston JB, 2000, DRUG METAB DISPOS, V28, P246
[9]
Metabolism of flavonoids via enteric recycling: Mechanistic studies of disposition of apigenin in the Caco-2 cell culture model [J].
Hu, M ;
Chen, J ;
Lin, HM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) :314-321
[10]
Atypical kinetic profiles in drug metabolism reactions [J].
Hutzler, JM ;
Tracy, TS .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (04) :355-362